| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $4,876 | $5,195 | $5,522 | $7,364 | $8,562 |
| Gross Profit | $1,830 | $1,975 | $2,084 | $2,717 | $3,212 |
| Operating Income | $367 | $585 | $622 | $652 | $1,009 |
| Net Income | $254 | $427 | $355 | $609 | $890 |

Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $4,876 | $5,195 | $5,522 | $7,364 | $8,562 |
| Gross Profit | $1,830 | $1,975 | $2,084 | $2,717 | $3,212 |
| Operating Income | $367 | $585 | $622 | $652 | $1,009 |
| Net Income | $254 | $427 | $355 | $609 | $890 |
Over the five-year period, Xylem Inc. shows a generally positive and strengthening financial performance. Revenue grew from US$4,876 million in 2020 to US$8,562 million in 2024. Notably, while the growth between 2020 and 2022 was moderate (roughly 6% to 7% annually), 2023 saw a significant jump of about 33% in revenue, followed by a 16% increase in 2024. Gross profit has tracked this upward trend, growing steadily from US$1,830 million in 2020 to US$3,212 million in 2024. This reflects improved sales volumes or margins, or both, during periods of market recovery or operational improvements. However, the operating income and net income metrics reveal additional layers in performance. Operating income experienced a notable surge from US$367 million in 2020 to US$585 million in 2021—a more than 50% increase—although it then plateaued around US$622–652 million for the next few years until a marked improvement to US$1,009 million in 2024, reflecting operational leverage and perhaps enhanced cost controls. Meanwhile, net income had a slight setback in 2022 (declining about 17% from 427 to 355 million) but then rebounded strongly in 2023 and 2024, moving from US$609 million to US$890 million. The significant swings—especially the 33% revenue jump in 2023 and the 54% increase in operating income in 2024—may be driven by market expansion, higher demand in water technology and infrastructure investments, or strategic operational adjustments. Overall, Xylem’s consistent top-line growth coupled with marked improvements in profitability indicates a robust financial health and a sustainable growth outlook in its specialized industry.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.